FDA advisers back Moderna’s Covid booster for at-risk groups

Panel recommends third jabs for vulnerable people in step towards expanding US rollout of extra doses
Source: FT.com - Drugs and Healthcare - Category: Pharmaceuticals Source Type: news
More News: Pharmaceuticals